
Loading, please wait...

Loading, please wait...

Acrylamide is a probable human carcinogen that frequently appears in thermally processed starchy foods like potato chips and biscuits. Because of its reactive nature, researchers are exploring dietary strategies for acrylamide metabolism mitigation. A recent study has highlighted the significant potential of thiol compounds, specifically glutathione and cysteine, in reducing the toxicological impact of this process contaminant during the digestive process.
During simulated gastric and intestinal digestion, control potato chips showed a natural decline in acrylamide levels. However, the incorporation of thiol compounds significantly enhanced this elimination. Specifically, adding 1% glutathione or 0.5% cysteine achieved substantial reductions during the oral and gastric phases. Consequently, these compounds lower the bioaccessible fraction of acrylamide that the body might otherwise absorb. This reaction occurs because the sulfur-containing groups in thiols bind to acrylamide, effectively neutralizing its reactivity before it enters systemic circulation.
In vivo studies involving mouse models provided further evidence of the benefits of these thiol compounds. Mice fed chips reformulated with cysteine exhibited significantly lower levels of urinary biomarkers, such as AAMA and GAMA. These biomarkers are standard indicators of internal acrylamide exposure. Notably, while glutathione consumption led to higher AAMA levels, it resulted in lower GAMA, the more genotoxic metabolite. Therefore, these results suggest that thiols not only reduce initial exposure but also enhance detoxification pathways within the liver and kidneys.
The findings suggest that food reformulation is a viable public health strategy. By adding cysteine or glutathione to high-risk products, manufacturers can significantly decrease the carcinogen load. Moreover, clinical professionals may consider the co-consumption of thiol-rich foods as a protective measure against dietary contaminants. This approach aligns with global food safety goals to keep acrylamide exposure as low as reasonably achievable. Additionally, monitoring biomarkers like AAMA and GAMA could provide a more accurate assessment of individual risk in populations with high fried-food consumption.
Acrylamide forms naturally in starchy foods cooked at high temperatures, such as frying, roasting, or baking. Common sources include potato chips, French fries, coffee, and toasted bread.
These thiol compounds react with acrylamide in the gastrointestinal tract to form non-toxic adducts. This process reduces the amount of free acrylamide available for absorption and enhances the excretion of its metabolites.
AAMA and GAMA are mercapturic acid derivatives excreted in urine. They serve as reliable biomarkers for recent acrylamide exposure and provide insight into how the body is metabolizing the compound.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Mogol BA et al. Role of glutathione and cysteine in acrylamide metabolism during in vitro and in vivo digestion. J Sci Food Agric. 2026 Mar 12. doi: 10.1002/jsfa.70571. PMID: 41820250.
2. Boettcher MI et al. Mercapturic acids of acrylamide and glycidamide as biomarkers of the internal exposure to acrylamide in the general population. Mutat Res. 2005 Feb 7;580(1-2):167-76.
3. Food Safety and Standards Authority of India (FSSAI). Guidance to prevent and reduce formation of acrylamide in potato products. 2023.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research explores how thiol compounds like glutathione and cysteine reduce acrylamide levels during digestion, offering a way to mitigate carcinogen ris...
5 months ago

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today